United States Tasigna Market Report 2017

In this report, the United States Tasigna market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Tasigna in these regions, from 2012 to 2022 (forecast).

United States Tasigna market competition by top manufacturers/players, with Tasigna sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis Pharma
Harbin Pharmaceutical Group

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
200 mg Capsule
150 mg Capsule
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Tasigna for each application, including